Lysine-derived alkaloids: Overview and update on biosynthesis and medicinal applications with emphasis on quinolizidine alkaloids

Mini-Reviews in Medicinal Chemistry

Volumn 16, Issue , 2016, Pages

  Bunsupa, Somnuk ^a,b   Yamazaki, Mami ^a   Saito, Kazuki ^a  

^a CHIBA UNIVERSITY   (Japan)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Anabasine; Indolizidine alkaloids; Lycopodium alkaloids; Lysine derived alkaloids; Piperidine alkaloids; Plastidderived alkaloids; Quinolizidine alkaloids

Indexed keywords

ALKALOID DERIVATIVE; INDOLIZIDINE ALKALOID; LYSINE DERIVATIVE; PIPERIDINE DERIVATIVE; QUINOLIZIDINE DERIVATIVE; TRANSCRIPTOME; ALKALOID; INDOLIZIDINE DERIVATIVE; LYSINE; PIPERIDINE;

CELL COMPARTMENTALIZATION; DRUG SYNTHESIS; ELECTROSPRAY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; HUMAN; LIQUID CHROMATOGRAPHY; LYCOPODIUM; MASS FRAGMENTOGRAPHY; NONHUMAN; QUADRUPOLE MASS SPECTROMETRY; REVIEW; THIN LAYER CHROMATOGRAPHY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BIOSYNTHESIS; CHEMISTRY; METABOLISM; PLANT;

ALKALOIDS; INDOLIZIDINES; LYCOPODIUM; LYSINE; PIPERIDINES; PLANTS; QUINOLIZIDINES;

EID: 85010651877     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557516666160506151213     Document Type: Review

References (117)

1. Facchini, P.J. Alkaloid biosynthesis in plants: biochemistry, cell biology, molecular regulation, and metabolic engineering applications. Annu. Rev. Plant Physiol. Plant Mol. Biol., 2001, 52(1), 29-66.
2. De Luca, V.; Laflamme, P. The expanding universe of alkaloid biosynthesis. Curr. Opin. Plant Biol., 2001, 4(3), 225-233.
3. De Luca, V.; Salim, V.; Atsumi, S.M.; Yu, F. Mining the biodiversity of plants: a revolution in the making. Science, 2012, 336(6089), 1658-1661.
4. Galili, G. New insights into the regulation and functional significance of lysine metabolism in plants. Annu. Rev. Plant Biol., 2002, 53(1), 27-43.
5. Tomar, P.C.; Lakra, N.; Mishra, S.N. Cadaverine: a lysine catabolite involved in plant growth and development. Plant Signal. Behav., 2013, 8(10), e25850.
6. Azevedo, R.A.; Arruda, P.; Turner, W.L.; Lea, P.J. The biosynthesis and metabolism of the aspartate derived amino acids in higher plants. Phytochemistry, 1997, 46(3), 395-419.
7. Bunsupa, S.; Yamazaki, M.; Saito, K. Quinolizidine alkaloid biosynthesis: recent advances and future prospects. Front. Plant Sci., 2012, 3, 239.
8. Bunsupa, S.; Katayama, K.; Ikeura, E.; Oikawa, A.; Toyooka, K.; Saito, K.; Yamazaki, M. Lysine decarboxylase catalyzes the first step of quinolizidine alkaloid biosynthesis and coevolved with alkaloid production in Leguminosae. Plant Cell, 2012, 24(3), 1202-1216.
9. Dewick, P.M. Medicinal Natural Products: A Biosynthetic Approach, 2nd ed.; Wiley & Sons: West Sussex, 2001.
10. Wink, M.; Meißner, C.; Witte, L. Patterns of quinolizidine alkaloids in 56 species of the genus Lupinus. Phytochemistry, 1995, 38(1), 139-153.
11. Ohmiya, S.; Saito, K.; Murakoshi, I. In: The Alkaloids: Chemistry and Pharmacology; Cordell, G.A., Ed.; Academic Press: London, 1995; Vol. 47, pp. 1-114.
12. Wink, M. In: Insect-Plant Interactions; Bernays E.A., Ed.; CRC Press: Boca Raton, 1992; Vol. 4, pp. 131-166.
13. Wróbel, J.T. In: The Alkaloids: Chemistry and Physiology; Manske, R.H.F., Ed.; Academic Press: London, 1977; Vol. 17, pp. 181-214.
14. Wink, M.; Witte, L. Cell-free synthesis of the alkaloids ammodendrine and smipine. Z. Naturforsch. C, 1987, 42(3), 197-204.
15. Zhang Y.F.; Zhao Q.Q.; Shao Q.; Fan X.H. Simultaneous determination of two types of active components with different physicochemical properties in Kushen by HPLC-UV. Chem. Res. Chin. Univ., 2011, 27(3), 375-379.
16. Wong, S.K.; Tsui, S.K.; Kwan, S.Y. Analysis of proprietary Chinese medicines for the presence of toxic ingredients by LC/MS/MS. J. Pharm. Biomed. Anal. 2002, 30(1), 161-170.
17. Wang, H.; Guo, S.; Qian, D.; Qian, Y.; Duan, J. Comparative analysis of quinolizidine alkaloids from different parts of Sophora alopecuroides seeds by UPLC-MS/MS. J. Pharm. Biomed. Anal., 2012, 67-68, 16-21.
18. Golebiewski, W.M.; Spenser, I.D. Biosynthesis of the lupine alkaloids. II. Sparteine and lupanine. Can. J. Chem., 1988, 66(7), 1734-1748.
19. Leeper, F.J.; Grue-Sørensen, G.; Spenser, I.D. Biosynthesis of the quinolizidine alkaloids. Incorporation of 1-piperideine into matrine. Can. J. Chem., 1981, 59(1), 106-115.
20. Wink, M. Quinolizidine alkaloids: biochemistry, metabolism, and function in plants and cell suspension cultures. Planta Med., 1987, 53(6), 509-514.
21. Leistner, E.; Spenser I.D. Biosynthesis of the piperidine nucleus. Incorporation of chirally labeled cadaverine [1-3H]. J. Am. Chem. Soc., 1973, 95(14), 4715-4725.
22. Brown, A.M.; Robins, D.J.; Witte, L.; Wink, M. Stereochemistry of enzymic reactions involved in the formation of tetrahydroanabasine, ammodendrine, smipine and tripiperideine. Plant Physiol. (Life Sci. Adv.), 1992, 10, 179-185.
23. Perrey, R.; Wink, M. On the role of Δ1-piperideine and tripiperideine in the biosynthesis of quinolizidine alkaloids. Z. Naturforsch. C, 1988, 43(5-6), 363-369.
24. Saito K.; Murakoshi I. In: Studies in Natural Products Chemistry: Structure and Chemistry (Part C); Atta-ur-Rahman, Ed.; Elsevier: Amsterdam, 1995, Vol. 15, pp. 519-550.
25. Hirai, M.Y.; Suzuki, H.; Yamazaki, M.; Saito, K. Biochemical and partial molecular characterization of bitter and sweet forms of Lupinus angustifolius, an experimental model for study of molecular regulation of quinolizidine alkaloid biosynthesis. Chem. Pharm. Bull. (Tokyo), 2000, 48(10), 1458-1461.
26. Bunsupa, S.; Okada, T.; Saito, K.; Yamazaki, M. An acyltransferase-like gene obtained by differential gene expression profiles of quinolizidine alkaloid-producing and nonproducing cultivars of Lupinus angustifolius. Plant Biotechnol., 2011, 28(1), 89-94.
27. Okada, T.; Hirai, M.Y.; Suzuki, H.; Yamazaki, M.; Saito, K. Molecular characterization of a novel quinolizidine alkaloid Otigloyltransferase: cDNA cloning, catalytic activity of recombinant protein and expression analysis in Lupinus plants. Plant Cell Physiol., 2005, 46(1), 233-244.
28. Bagni, N.; Tassoni, A. Biosynthesis, oxidation and conjugation of aliphatic polyamines in higher plants. Amino Acids, 2001, 20(3), 301-317.
29. Wink, M. The plant vacuole: a multifunctional compartment. J. Exp. Bot., 1993, 44, 231-246.
30. Mende, P.; Wink, M. Uptake of the quinolizidine alkaloid lupanine by protoplasts and isolated vacuoles of suspension-cultured Lupinus polyphyllus cells. Diffusion or carrier-mediated transport? J. Plant Physiol., 1987, 129(3), 229-242.
31. Lee, M.J.; Pate, J.S.; Harris, D.J.; Atkins, C.A. Synthesis, transport and accumulation of quinolizidine alkaloids in Lupinus albus L. and L. angustifolius L. J. Exp. Bot., 2007, 58(5), 935-946.
32. Suzuki, H.; Koike, Y.; Murakoshi, I.; Saito, K. Subcellular localization of acyltransferases for quinolizidine alkaloid biosynthesis in Lupinus. Phytochemistry, 1996, 42(6), 1557-1562.
33. McGaw, B.A.; Woolley, J.G. Non-reversibility of the isoleucineacetate pathway in Datura. Phytochemistry, 1977, 16(11), 1711-1713.
34. Leete, E. Biosynthetic conversion of α-methylbutyric acid to tiglic acid in Datura meteloides. Phytochemistry, 1973, 12(9), 2203-2205.
35. Patel, T.B.; Waymack, P.P.; Olson, M.S. The effect of the monocarboxylate translocator inhibitor, α-cyanocinnamate, on the oxidation of branched chain α-keto acids in rat liver. Arch. Biochem. Biophys., 1980, 201(2), 629-635.
36. Hughes, W.A.; Halestrap, A.P. The regulation of branched-chain 2-oxo acid dehydrogenase of liver, kidney and heart by phosphorylation. Biochem. J., 1981, 196(2), 459-469.
37. Wink, M. In: The Alkaloids: Chemistry and Pharmacology; Cordell, G.A., Ed.; Academic Press: London, 1993; Vol. 43, pp. 1-118.
38. Kinghorn, A.D.; Balandrin M.F. In: The Alkaloids: Chemical and Biological Perspectives, Pelletier, W.S., Ed.; Wiley/Interscience: New York, 1984; Vol. 15, pp. 105-148.
39. Schmeller, T.; Sauerwein, M.; Sporer, F.; Wink, M.; Müller, W.E. Binding of quinolizidine alkaloids to nicotinic and muscarinic acetylcholine receptors. J. Nat. Prod., 1994, 57(9), 1316-1319.
40. Wink, M. In: Studies in Natural Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier: New York, 2000; Vol. 21, pp. 3-122.
41. Körper, S.; Wink, M.; Fink, R.H. Differential effects of alkaloids on sodium currents of isolated single skeletal muscle fibers. FEBS Lett., 1998, 436(2), 251-255.
42. Tang, W.; Eisenbrand, G. Chinese Drugs of Plant Origin: Chemistry, Pharmacology, and Use in Traditional and Modern Medicine, 1st ed.; Springer-Verlag: Heidelberg, 1992.
43. Cho, C.; Chuang, C.; Chen, C. Study of the antipyretic activity of matrine. A lupin alkaloid isolated from Sophora subprostrata. Planta Med., 1986, 52(5), 343-345.
44. Liu, X.S.; Jiang, J.; Jiao, X.Y.; Wu, Y.E.; Lin, J.H. Matrineinduced apoptosis in leukemia U937 cells: involvement of caspases activation and MAPK-independent pathways. Planta Med., 2006, 72(6), 501-506.
45. Long, Y.; Lin, X.T.; Zeng, K.L.; Zhang, L. Efficacy of intramuscular matrine in the treatment of chronic hepatitis B. Hepatob. Pancreat. Dis., 2004, 3(1), 69-72.
46. Dong, Y.; Xi, H.; Yu, Y.; Wang, Q.; Jiang, K.; Li, L. Effects of oxymatrine on the serum levels of T helper cell 1 and 2 cytokines and the expression of the S gene in hepatitis B virus S gene transgenic mice: A study on the anti-hepatitis B virus mechanism of oxymatrine. J. Gastroen. Hepatol., 2002, 17(12), 1299-1306.
47. Goto, T.; Hirazawa, N.; Takaishi, Y.; Kashiwada, Y. Antiparasitic effect of matrine and oxymatrine (quinolizidine alkaloids) on the ciliate Cryptocaryon irritans in the red sea bream Pagrus major. Aquaculture, 2015, 437, 339-343.
48. Hong-Li, S.; Lei, L.; Lei, S.; Dan, Z.; De-Li, D.; Guo-Len, Q.; Yan, L.; Wen-Feng, C.; Bao-Feng, Y. Cardioprotective effects and underlying mechanisms of oxymatrine against ischemic myocardial injuries of rats. Phytother. Res., 2008, 22(7), 985-989.
49. Ma, L.; Wen, S.; Zhan, Y.; He, Y.; Liu, X.; Jiang, J. Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells. Planta Med., 2008, 74(3), 245-251.
50. Song, G.; Luo, Q.; Qin, J.; Wang, L.; Shi, Y.; Sun, C. Effects of oxymatrine on proliferation and apoptosis in human hepatoma cells. Colloids Surface B, 2006, 48(1), 1-5.
51. Liang, R.; Zhang, W.; Jin, S. Inhibitory effect of oxymatrine on the proliferation and vascular endothelial growth factor A (VEGF-A) expression in human lung adenocarcinoma (SPC-A-1) cell. Afr. J. Pharm. Pharmacol., 2012, 6(46), 3195-3200.
52. Zhang, J.P.; Zhang, M.; Zhou, J.P.; Liu, F.T.; Zhou, B.; Xie, W.F.; Guo, C.; Zhang, C.; Qian, D.H. Antifibrotic effects of matrine on in vitro and in vivo models of liver fibrosis in rats. Acta Pharmacol. Sin 2001, 22(2), 183-186.
53. Yang, J.M.; Ip, S.P.; Xian, Y.; Zhao, M.; Lin, Z.X.; Yeung, J.H.K.; Chan, R.C.Y.; Lee, S.S.; Che, C.T. Impact of the herbal medicine Sophora flavescens on the oral pharmacokinetics of indinavir in rats: the involvement of CYP3A and P-glycoprotein. PLoS ONE, 2012, 7(2): e31312.
54. Pothier, J.; Cheav, S.L.; Galand, N.; Dormeau, C.; Viel, C. A comparative study of the effects of sparteine, lupanine and lupin extract on the central nervous system of the mouse. J. Pharm. Pharmacol., 1998, 50(8), 949-954.
55. Berger, J.D.; Buirchell, B.; Luckett, D.J.; Palta, J.A.; Ludwig, C.; Liu, D. How has narrow-leafed lupin changed in its 1st 40 years as an industrial, broad-acre crop? A G x E-based characterization of yield-related traits in Australian cultivars. Field Crop Res., 2012, 126, 152-164.
56. Johnson, S.K.; McQuillan, P.L.; Sin, J.H.; Ball, M.J. Sensory acceptability of white bread with added Australian sweet lupin (Lupinus angustifolius) kernel fibre and its glycaemic and insulinaemic responses when eaten as a breakfast. J. Sci. Food Agric., 2003, 83(13), 1366-1372.
57. Yang, H.; Tao, Y.; Zheng, Z.; Zhang, Q.; Zhou, G.; Sweetingham, M.W.; Howieson, J.G.; Li, C. Draft genome sequence, and a sequence-defined genetic linkage map of the legume crop species Lupinus angustifolius L. PLoS ONE, 2013, 8(5):e64799.
58. Parra-González, L.; Aravena-Abarzua, G.; Navarro-Navarro, C.; Udall, J.; Maughan, J.; Peterson, L.; Salvo-Garrido, H.; Maureira-Butler, I. Yellow lupin (Lupinus luteus L.) transcriptome sequencing: molecular marker development and comparative studies. BMC Genomics, 2012, 13(1), 425.
59. O'Rourke, J.A.; Yang, S.S.; Miller, S.S.; Bucciarelli, B.; Liu, J.; Rydeen, A.; Bozsoki, Z.; Uhde-Stone, C.; Tu, Z.J.; Allan, D.; Gronwald, J.W.; Vance, C.P. An RNA-seq transcriptome analysis of orthophosphate-deficient white lupin reveals novel insights into phosphorus acclimation in plants. Plant Physiol., 2013, 161(2), 705-724.
60. Kamphuis, L.G.; Hane, J.K.; Nelson, M.N.; Gao, L.; Atkins, C.A.; Singh, K.B. Transcriptome sequencing of different narrow-leafed lupin tissue types provides a comprehensive uni-gene assembly and extensive gene-based molecular markers. Plant Biotechnol. J., 2015, 13(1), 14-25.
61. Han, R.; Takahashi, H.; Nakamura, M.; Bunsupa, S.; Yoshimoto, N.; Yamamoto, H.; Suzuki, H.; Shibata, D.; Yamazaki, M.; Saito, K. Transcriptome analysis of nine tissues to discover genes involved in the biosynthesis of active ingredients in Sophora flavescens. Biol. Pharm. Bull., 2015, 38(6), 876-883.
62. Ma, X.; Gang, D.R. The Lycopodium alkaloids. Nat. Prod. Rep., 2004, 21(6), 752-772.
63. Ma, X.; Tan, C.; Zhu, D.; Gang, D.R. Is there a better source of huperzine A than Huperzia serrata? Huperzine A content of Huperziaceae species in China. J. Agric. Food Chem., 2005, 53(5), 1393-1398.
64. Pan, K.; Luo, J.G.; Kong, L.Y. A new Lycopodium alkaloid from Phlegmariurus fargesii. Chin. J. Nat. Med., 2014, 12(5), 373-376.
65. Ying, Y.M.; Liu, X.S.; Tong, C.P.; Wang, J.W.; Zhan, Z.J.; Shan, W.G. Lycopodium alkaloids from Huperzia serrata. Helv. Chim. Acta, 2014, 97(10), 1433-1439.
66. Ishiuchi, K.; Park, J.J.; Long, R.M.; Gang, D.R. Production of huperzine A and other Lycopodium alkaloids in Huperzia species grown under controlled conditions and in vitro. Phytochemistry, 2013, 91, 208-219.
67. Siengalewicz, P.; Mulzer, J.; Rinner, U. In: The Alkaloids: Chemistry and Biology; Knölker, H.J., Ed.; Elsevier Inc: San Diego, 2013; Vol. 72, pp. 1-151.
68. Sun, J.; Morita, H.; Chen, G.; Noguchi, H.; Abe, I. Molecular cloning and characterization of copper amine oxidase from Huperzia serrata. Bioorg. Med. Chem. Lett., 2012, 22(18), 5784-5790.
69. Bai, D.L.; Tang, X.C.; He, X.C. Huperzine A, a potential therapeutic agent for treatment of Alzheimer’s disease. Curr. Med. Chem., 2000, 7(3), 355-374.
70. Qian, Z.M.; Ke, Y. Huperzine A: Is it an effective diseasemodifying drug for Alzheimer’s disease? Front. Aging Neurosci., 2014, 6, 216.
71. Wang, B.; Wang, H.; Wei, Z.; Song, Y.; Zhang, L.; Chen, H. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer’s disease: an updated meta-analysis. J. Neural Transm., 2009, 116(4), 457-465.
72. Ma, X.; Tan, C.; Zhu, D.; Gang, D.R.; Xiao, P. Huperzine A from Huperzia species - an ethnopharmacological review. J. Ethnopharmacol., 2007, 113(1), 15-34.
73. Jia, J.; Zhao, Q.; Liu, Y.; Gui, Y.; Liu, G.; Zhu, D.; Yu, C.; Hong, Z. Phase I study on the pharmacokinetics and tolerance of ZT-1, a prodrug of huperzine A, for the treatment of Alzheimer’s disease. Acta Pharmacol. Sin., 2013, 34(7), 976-982.
74. Leete, E. Biosynthesis of the hemlock and related piperidine alkaloids. Accounts Chem. Res., 1971, 4(3), 100-107.
75. Stöhr, J.R.; Xiao, P.G.; Bauer, R. Constituents of Chinese Piper species and their inhibitory activity on prostaglandin and leukotriene biosynthesis in vitro. J. Ethnopharmacol., 2001, 75(2-3), 133-139.
76. Kanaki, N.; Dave, M.; Padh, H.; Rajani, M. A rapid method for isolation of piperine from the fruits of Piper nigrum Linn. J. Nat. Med., 2008, 62(3), 281-283.
77. Felpin, F.X.; Lebreton, J. History, chemistry and biology of alkaloids from Lobelia inflata. Tetrahedron, 2004, 60(45), 10127-10153.
78. Geisler, J.G.; Gross, G.G. The biosynthesis of piperine in Piper nigrum. Phytochemistry, 1990, 29(2), 489-492.
79. Damaj, M.I.; Patrick, G.S.; Creasy, K.R.; Martin, B.R. Pharmacology of lobeline, a nicotinic receptor ligand. J. Pharmacol. Exp. Ther., 1997, 282(1), 410-419.
80. Sen, S.; Skaria, R.; Muneer, P.M.A. Genetic diversity analysis in Piper species (Piperaceae) using RAPD markers. Mol. Biotechnol., 2010, 46(1), 72-79.
81. Parmar, V.S.; Jain, S.C.; Bisht, K.S.; Jain, R.; Taneja, P.; Jha, A.; Tyagi, O.D.; Prasad, A.K.; Wengel, J.; Olsen, C.E.; Boll, P.M. Phytochemistry of the genus Piper. Phytochemistry, 1997, 46(4), 597-673.
82. Duangjai, A.; Ingkaninan, K.; Praputbut, S.; Limpeanchob, N. Black pepper and piperine reduce cholesterol uptake and enhance translocation of cholesterol transporter proteins. J. Nat. Med., 2013, 67(2), 303-310.
83. Meghwal, M.; Goswami, T.K. Piper nigrum and piperine: an update. Phytother. Res., 2013, 27(8), 1121-1130.
84. Wang, R.; Ding, Y.; Liu, R; Xiang, L.; Du, L. Pomegranate: constituents, bioactivities and pharmacokinetics. Fruit Veg. Cereal Sci. Biotech., 2010, 4(2), 77-87.
85. Lansky, E.P.; Newman, R.A. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J. Ethnopharmacol., 2007, 109(2), 177-206.
86. Jurenka, J.S. Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern. Med. Rev., 2008, 13(2), 128-144.
87. Gellert, E. The indolizidine alkaloids. J. Nat. Prod., 1982, 45(1), 50-73.
88. Colegate, S.M.; Dorling, P.R.; Huxtable, C.R. A spectroscopic investigation of swainsonine: an ‑ mannosidase inhibitor isolated from Swainsona canescens. Aust. J. Chem., 1979, 32(10), 2257-2264.
89. Kato, A.; Hirokami, Y.; Kinami, K.; Tsuji, Y.; Miyawaki, S.; Adachi, I.; Hollinshead, J.; Nash, R.J.; Kiappes, J.L.; Zitzmann, N.; Cha, J.K.; Molyneux, R.J.; Fleet, G.W.J.; Asano, N. Isolation and SAR studies of bicyclic iminosugars from Castanospermum australe as glycosidase inhibitors. Phytochemistry, 2015, 111, 124-131.
90. Gardner, D.R.; Molyneux, R.J.; Ralphs, M.H. Analysis of swainsonine: extraction methods, detection, and measurement in populations of locoweeds (Oxytropis spp.). J. Agric. Food Chem., 2001, 49(10), 4573-4580.
91. Whitby, K.; Taylor, D.; Patel, D.; Ahmed, P.; Tyms, A.S. Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C. Antivir. Chem. Chemother., 2004, 15(3), 141-151.
92. Tanaka, Y.; Kato, J.; Kohara, M.; Galinski, M.S. Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3. Antiviral Res., 2006, 72(1), 1-9.
93. Whitby, K.; Pierson, T.C.; Geiss, B.; Lane, K.; Engle, M.; Zhou, Y.; Doms, R.W.; Diamond, M.S. Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. J. Virol., 2005, 79(14), 8698-8706.
94. Watanabe, S.; Rathore, A.P.S.; Sung, C.; Lu, F.; Khoo, Y.M.; Connolly, J.; Low, J.; Ooi, E.E.; Lee, H.S.; Vasudevan, S.G. Doseand schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial. Antiviral Res., 2012, 96(1), 32-35.
95. Allan, G.; Ouadid-Ahidouch, H.; Sanchez-Fernandez, E.M.; Risquez-Cuadro, R.; Fernandez, J.M.G.; Ortiz-Mellet, C.; Ahidouch, A. New castanospermine glycoside analogues inhibit breast cancer cell proliferation and induce apoptosis without affecting normal cells. PLoS ONE, 2013, 8(10): e76411.
96. Sánchez-Fernández, E.M.; Rísquez-Cuadro, R.; Chasseraud, M.; Ahidouch, A.; Mellet, C.O.; Ouadid-Ahidouch, H.; Fernández, J.M.G. Synthesis of N-, S-, and C-glycoside castanospermine analogues with selective neutral α-glucosidase inhibitory activity as antitumour agents. Chem. Commun., 2010, 46(29), 5328-5330.
97. Li, Z.; Li, T.; Dai, S.; Xie, X.; Ma, X.; Zhao, W.; Zhang, W.; Li, J.; Wang, P.G. New insights into the pharmacological chaperone activity of C2-substituted glucoimidazoles for the treatment of Gaucher disease. Chem. Bio. Chem., 2013, 14(10), 1239-1247.
98. Luan, Z.; Higaki, K.; Aguilar-Moncayo, M.; Ninomiya, H.; Ohno, K.; García-Moreno, M.I.; Ortiz Mellet, C.; García Fernández, J.M.; Suzuki, Y. Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(nnonyl) deoxynojirimycin. Chem. Bio. Chem., 2009, 10(17), 2780-2792.
99. Durantel, D. Celgosivir, an α-glucosidase I inhibitor for the potential treatment of HCV infection. Curr. Opin. Investig. Drugs, 2009, 10(8), 860-870.
100. Low, J.G.; Sung, C.; Wijaya, L.; Wei, Y.; Rathore, A.P.S.; Watanabe, S.; Tan, B.H.; Toh, L.; Chua, L.T.; Hou, Y.; Chow, A.; Howe, S.; Chan, W.K.; Tan, K.H.; Chung, J.S.; Cherng, B.P.; Lye, D.C.; Tambayah, P.A.; Ng, L.C.; Connolly, J.; Hibberd, M.L.; Leo, Y.S.; Cheung, Y.B.; Ooi, E.E.; Vasudevan, S.G. Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): A phase 1b, randomised, double-blind, placebo-controlled, proof-ofconcept trial. Lancet Infect. Dis., 2014, 14(8), 706-715.
101. Whitby, K.; Taylor, D.; Patel, D.; Ahmed, P.; Tyms, A.S. Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C. Antivir. Chem. Chemother., 2004, 15(3), 141-151.
102. Saitoh, F.; Noma, M.; Kawashima, N. The alkaloid contents of sixty Nicotiana species. Phytochemistry, 1985, 24(3), 477-480.
103. Steenkamp, P.A.; van Heerden, F.R.; van Wyk, B.E. Accidental fatal poisoning by Nicotiana glauca: identification of anabasine by high performance liquid chromatography/photodiode array/mass spectrometry. Forensic Sci. Int., 2002, 127(3), 208-217.
104. Mizrachi, N.; Levy, S.; Goren, Z.Q. Fatal poisoning from Nicotiana glauca leaves: identification of anabasine by gaschromatography/ mass spectrometry. J. Forensic Sci., 2000, 45(3), 736-741.
105. Bunsupa, S.; Komatsu, K.; Nakabayashi, R. Revisiting anabasine biosynthesis in tobacco hairy roots expressing plant lysine decarboxylase gene by using 15N-labeled lysine. Plant Biotechnol., 2014, 31, 511-518.
106. Shoji, T.; Hashimoto, T. Why does anatabine, but not nicotine, accumulate in jasmonate-elicited cultured tobacco BY-2 cells? Plant Cell Physiol., 2008, 49(8), 1209-1216.
107. Leete, E. The biogenesis of nicotine and anabasine. J. Am. Chem. Soc., 1956, 78(14), 3520-3523.
108. Leete, E.; Siegfried, K.J. The biogenesis of nicotine. III. Further observations on the incorporation of ornithine into the pyrrolidine ring. J. Am. Chem. Soc., 1957, 79(16), 4529-4531.
109. Leistner, E.; Spenser, I.D. Biosynthesis of the piperidine nucleus. Incorporation of chirally labeled [1-3H] cadaverine. J. Am. Chem. Soc., 1973, 95(14), 4715-4725.
110. Walton, N.J.; Robins, R.J.; Rhodes, M.J. Perturbation of alkaloid production by cadaverine in hairy root cultures of Nicotiana rustica. Plant Sci., 1988, 54(2), 125-131.
111. DeBoer, K.D.; Dalton, H.L.; Edward, F.J.; Ryan, S.M.; Hamill, J.D. RNAi-mediated down-regulation of ornithine decarboxylase (ODC) impedes wound-stress stimulation of anabasine synthesis in Nicotiana glauca. Phytochemistry, 2013, 86, 21-28.
112. Kajikawa, M.; Hirai, N.; Hashimoto, T. A PIP-family protein is required for biosynthesis of tobacco alkaloids. Plant Mol. Biol., 2009, 69(3), 287-298.
113. Lee, S.T.; Wildeboer, K.; Panter, K.E.; Kem, W.R.; Gardner, D.R.; Molyneux, R.J.; Chang, C.W.T.; Soti, F.; Pfister, J. Relative toxicities and neuromuscular nicotinic receptor agonistic potencies of anabasine enantiomers and anabaseine. Neurotoxicol. Teratol., 2006, 28(2), 220-228.
114. Yonekura-Sakakibara, K.; Fukushima, A.; Saito, K. Transcriptome data modeling for targeted plant metabolic engineering. Curr. Opin. Biotech., 2013, 24(2), 285-290.
115. Saito, K. Phytochemical genomics ‑ a new trend. Curr. Opin. Plant Biol., 2013, 16(3), 373-380.
116. Sumner, L.W.; Lei, Z.; Nikolau, B.J.; Saito, K. Modern plant metabolomics: advanced natural product gene discoveries, improved technologies, and future prospects. Nat. Prod. Rep., 2015, 32(2), 212-229.
117. Goossens, A. It is easy to get huge candidate gene lists for plant metabolism now, but how to get beyond? Mol. Plant, 2015, 8(1), 2-5.